Autosomal Dominant Polycystic Kidney

Nephrology·MeSH: Polycystic Kidney, Autosomal Dominant

10 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
bardoxolone	REATA PHARMACEUTICALS INC (RETA)

Phase 1(9)

Drug	Company
azd1613 - part a	ASTRAZENECA PLC (AZN)
azd1613 - part b	ASTRAZENECA PLC (AZN)
drsp/ee	VERTEX PHARMACEUTICALS INC / MA (VRTX)
farabursen	Regulus Therapeutics Inc. (RGLS)
lng/ee	VERTEX PHARMACEUTICALS INC / MA (VRTX)
net/ee	VERTEX PHARMACEUTICALS INC / MA (VRTX)
ngm/ee	VERTEX PHARMACEUTICALS INC / MA (VRTX)
rgls8429	Regulus Therapeutics Inc. (RGLS)
vx-407	VERTEX PHARMACEUTICALS INC / MA (VRTX)

BioSniper tracks 10 drugs in development for Autosomal Dominant Polycystic Kidney across 4 companies.

There are 1 clinical trial targeting Autosomal Dominant Polycystic Kidney tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.